Skip to content
Colgate Palmolive logo

Colgate Palmolive

Colgate-Palmolive (India) Ltd

COLPAL NSE
₹1,760.00 −16.60 (−0.93%)
Market Cap
₹47,869 Cr
P/E
35.15
View as Markdown
MCP
Close 20 Nov 2026 ₹1,760.00 1Y −396.70 −18.4%
Start ₹2,156.70

Key Fundamentals

MidcapPersonal ProductsFMCG

Price-based figures as of · EPS basis: Standalone · TTM

ROCE
108.00%
Debt to Equity
0.03
EPS (TTM)
₹50.07
Book Value
₹59.45
Market Cap
₹47,869 Cr
P/E (TTM)
35.15
P/B
29.60
ROE
82.70%
Dividend Yield
1.35%
EBITDA
₹1,959 Cr
52W High
₹2,301.60
52W Low
₹1,563.90
Day Range
₹1,756.50 – ₹1,782.30
Volume
3,51,315

Peer Comparison

Fast Moving Consumer Goods › Personal Products › Personal Care

Colgate Palmolive peer comparison
919.5047.5794,0937.461.67%16.10%18.80%16,5371,978
393.1034.4269,7346.070.92%17.00%20.30%13,9242,001
365.65290.2049,16887.481.38%27.60%33.90%602169
Colgate Palmolive (this company)
1,760.0035.1547,86929.601.42%82.70%108.00%6,3911,362
7,090.5033.8023,10521.513.31%66.50%90.70%3,211683
7,020.0029.3422,78725.783.73%115.00%157.00%4,240776
422.2024.7618,4296.301.21%26.20%28.10%4,204747
Median 7 companies919.5034.4247,86921.511.42%27.60%33.90%4,240776

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

55 Good

Data confidence 100/100

Category scores

Quality
85
Strong
Returns, margins, earnings quality 22% weight
Valuation
36
Poor
Cheap vs sector & own history 24% weight
Growth
50
Average
Sales & profit trajectory 9% weight
Financial Health
91
Strong
Solvency, leverage, coverage 9% weight
Momentum
33
Poor
Trend strength, vol-adjusted 12% weight
Ownership
46
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 79.4%
  • Company has been maintaining a healthy dividend payout of 112%

Weaknesses

2
  • Stock is trading at 29.6 times its book value
  • The company has delivered a poor sales growth of 4.51% over past five years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBullish748
OscillatorsBearish342
Moving AveragesStrong Bullish406

Key readings

RSI (14)
55.98
Neutral
MACD (12,26,9)
1.94
Bullish
SMA (50)
1,748.61
Bullish
SMA (200)
1,969.92
Bearish

As of

Analyst Rating

Based on 26 analysts
SELL38%

7 of 26 analysts rate Buy, 9 Hold, 10 Sell.

As of

BUY
7
27%
HOLD
9
35%
SELL
10
38%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.

Revenue

Revenue growth by window
10Y+4.55%
5Y+4.51%
3Y+4.91%
1Y−0.08%
TTM+8.69%

Net profit

Net profit growth by window
10Y+8.59%
5Y+5.06%
3Y+8.17%
1Y−7.79%
TTM+2.64%

Operating cash flow

Operating cash flow growth by window
10Y+10.12%
5Y+18.16%
3Y+15.37%
1Y+29.56%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+6.69 pp
5Y−0.20 pp
3Y+1.39 pp
1Y−1.43 pp
TTM−1.95 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹3,982 Cr
Mar 2018₹4,188 Cr
Mar 2019₹4,462 Cr
Mar 2020₹4,525 Cr
Mar 2021₹4,841 Cr
Mar 2022₹5,100 Cr
Mar 2023₹5,226 Cr
Mar 2024₹5,680 Cr
Mar 2025₹6,040 Cr
Mar 2026₹6,035 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹577 Cr
Mar 2018₹673 Cr
Mar 2019₹776 Cr
Mar 2020₹816 Cr
Mar 2021₹1,035 Cr
Mar 2022₹1,078 Cr
Mar 2023₹1,047 Cr
Mar 2024₹1,324 Cr
Mar 2025₹1,437 Cr
Mar 2026₹1,325 Cr

Analyst Forecasts

Forecast For
Dec 26 consensus · EBITDA
₹491 Cr −0.8% vs Sep 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 17 Nov 2026
AI opinion · based on fundamentals
Risk medium

Colgate-Palmolive (India) Ltd trades at ₹1,719.7 as of 2026-11-17 with a market cap of ₹46,773 crore, a trailing P/E of 34.35x, and an exceptionally high ROE of 83.66%. The company is virtually debt-free with a debt-to-equity ratio of 0.03 but has seen its stock decline roughly 25% from its 52-week high of ₹2,301.6, reflecting investor concerns around tepid profit growth and rich valuations.

Bull Case 7
  • Near-zero leverage with a debt-to-equity ratio of just 0.03, providing significant financial flexibility and resilience through economic cycles.
  • Exceptional return on equity of 83.66% and ROCE of 107.36% as of 2026-11-17, indicating highly efficient capital deployment relative to almost any listed FMCG peer.
  • Consistent ROE track record averaging 79% over 3 years and 75% over 5 years, demonstrating durable competitive advantages in oral care.
  • Healthy dividend payout of 112% with a current dividend yield of 1.41%, making it attractive for income-oriented portfolios in the FMCG space.
  • TTM sales growth has accelerated to 9%, meaningfully above the 5% compounded sales growth seen over both 3-year and 5-year periods, suggesting improving top-line momentum.
  • Compounded sales growth of 5% over 10 years reflects steady, defensive revenue characteristics typical of a dominant oral care franchise in India.
  • Stock is trading 25.3% below its 52-week high of ₹2,301.6, offering a more compressed entry valuation compared to recent peaks.
Bear Case 7
  • Price-to-book ratio of 28.91x is extremely high, reflecting a stock priced for perfection with minimal room for execution missteps.
  • Compounded profit growth of just 5% over 5 years and 4% on a TTM basis lags nominal GDP growth, raising questions about earnings power expansion.
  • Stock CAGR of -21% over the past 1 year and -7% over 3 years indicates sustained price underperformance, suggesting the market has been repricing the stock lower.
  • 5-year compounded sales growth of 5% is modest for an Indian FMCG company operating in a large underpenetrated market, pointing to potential category maturity in core oral care.
  • 10-year stock CAGR of only 6% has significantly underperformed broader Indian equity indices over the same period, questioning long-term wealth creation potential.
  • Dividend payout exceeding 112% of earnings means the company is returning more than it earns, which is unsustainable long-term unless earnings growth reaccelerates.
  • TTM EPS of ₹50.07 growing at just 4% offers limited near-term earnings catalyst to support the current 34.35x P/E multiple.

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

21h ago

TL;DR: Colgate-Palmolive (India) is returning cash to shareholders with a healthy ₹24 per share interim dividend and maintaining active investor engagement through multiple scheduled meets. A leadership transition is underway with a postal ballot for a new MD & CEO. No material headwinds emerged in recent news flow, though the upcoming leadership change warrants monitoring for strategic continuity.

Positives 1
  • ₹24 interim dividend declared Oct 23

    Colgate-Palmolive (India) declared a first interim dividend of ₹24 per share for FY26, with a record date of November 2, 2026.

Neutral 2
  • New MD & CEO appointment vote Oct 30

    Postal ballot initiated to appoint Manish Anandani as MD & CEO, with voting open from October 31 to November 29, 2026.

  • Multiple investor meets scheduled Nov 10

    Colgate-Palmolive (India) scheduled analyst/investor meetings on November 16, 18, and 26, 2026. No unpublished price-sensitive information will be shared.

Quarterly Results

₹ Cr
COLPAL quarterly results, ₹ crore
Particulars Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
1,471
1,396
1,490
1,497
1,619
1,462
1,463
1,434
1,520
1,486
1,595
1,603
1,706
Expenses
989
927
958
988
1,122
1,007
964
981
1,054
1,044
1,086
1,120
1,232
Operating Profit
482
468
532
508
497
454
498
453
465
442
510
483
473
OPM %
33%
34%
36%
34%
31%
31%
34%
32%
31%
30%
32%
30%
28%
Other Income
21
18
23
23
76
20
19
18
15
39.28
0
19
22
Interest
1
2
1
1
1
1
1
1
1
1
1
1
1
Depreciation
44
41
42
42
42
41
38
38
37
36
35
39
34
Exceptional Items
—
—
—
—
—
—
—
—
—
−8.39
—
—
—
PBT
458
443
511
489
530
433
478
432
442
436
474
462
460
Tax %
26%
26%
26%
26%
26%
25%
26%
26%
26%
26%
25%
26%
26%
Net Profit
340
330
380
364
395
323
355
321
328
324
353
343
342
EPS (₹)
12.50
12.14
13.96
13.38
14.52
11.87
13.05
11.79
12.04
11.91
12.99
12.61
12.56
YoY Sales growth
6
8
10
13
10
5
−2
−4
−6
2
9
12
12

Profit & Loss

₹ Cr
COLPAL profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
3,982
3,868
3,982
4,188
4,462
4,525
4,841
5,100
5,226
5,680
6,040
6,035
6,391
Expenses
3,159
2,929
3,038
3,074
3,226
3,323
3,331
3,534
3,679
3,779
4,082
4,165
4,482
Operating Profit
823
940
944
1,114
1,236
1,202
1,510
1,566
1,547
1,901
1,958
1,870
1,908
OPM %
21%
24%
24%
27%
28%
27%
31%
31%
30%
33%
32%
31%
30%
Other Income
32
7
41
26
37.66
49
30
26
53.58
76.52
139
89.12
72
Interest
0
0
0
0
2
10
7
6
5
5
4
4
4
Depreciation
75
111
133
157
159
198
182
177
175
172
163
146
145
Exceptional Items
—
—
—
—
30.51
—
—
—
−11.21
−19.5
—
−24.97
—
PBT
780
835
851
983
1,143
1,043
1,350
1,409
1,410
1,781
1,930
1,784
1,832
Tax %
28%
30%
32%
32%
32%
22%
23%
23%
26%
26%
26%
26%
—
Net Profit
559
581
577
673
776
816
1,035
1,078
1,047
1,324
1,437
1,325
1,362
EPS (₹)
20.55
21.37
21.23
24.76
28.52
30.02
38.07
39.65
38.50
48.67
52.83
48.73
50.07
Div. Payout %
58%
47%
47%
97%
81%
93%
100%
101%
101%
119%
97%
119%
—
Sales growth
11
−3
3
5
7
1
7
5
2
9
6
0
9

Balance Sheet

₹ Cr
COLPAL balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
14
27
27
27
27
27
27
27
27
27
27
27
27
Reserves
757
1,004
1,247
1,497
1,420
1,567
1,139
1,707
1,689
1,847
1,637
1,557
1,590
Borrowings
0
0
0
0
83
102
91
83
69
72
61
47
49
Other Liabilities
932
972
1,037
1,039
1,097
908
1,637
1,084
1,098
1,250
1,293
1,777
1,971
Total Liabilities
1,702
2,003
2,311
2,564
2,626
2,604
2,894
2,902
2,883
3,197
3,019
3,408
3,638
Fixed Assets
782
1,008
1,108
1,146
1,191
1,123
1,065
963
862
794
776
718
673
CWIP
141
78
167
159
199
190
145
122
114
110
38
27
52
Investments
37
31
31
31
31
19
19
0
0
0
0
0
0
Other Assets
742
885
1,005
1,228
1,206
1,272
1,666
1,817
1,907
2,292
2,204
2,663
2,913
Total Assets
1,702
2,003
2,311
2,564
2,626
2,604
2,894
2,902
2,883
3,197
3,019
3,408
3,638

Cash Flow

₹ Cr
COLPAL cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
638
689
688
694
983
930
784
1,626
1,176
1,199
1,394
1,806
Investing
−272
−237
−342
−207
−96
−19
71
−108
−8
79
56
374
Financing
−385
−391
−341
−380
−815
−891
−956
−1,091
−1,087
−1,195
−1,671
−1,422
Net Cash Flow
−18
61
5
107
73
20
−101
427
82
83
−221
758
Free Cash Flow
339
417
367
485
879
869
727
1,576
1,107
1,123
1,323
1,730
CFO/EBITDA
103
100
105
93
113
104
76
127
101
88
100
121

Ratios

COLPAL financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
6
10
12
18
17
11
9
16
11
11
14
13
Inventory Days
63
72
72
56
58
69
79
78
68
63
76
75
Days Payable
128
136
148
152
144
142
179
169
155
187
185
275
Cash Conversion Cycle
−59
−55
−63
−79
−68
−63
−91
−75
−76
−113
−95
−188
Working Capital Days
−40
−43
−39
−33
−36
−23
−84
−25
−32
−46
−37
−59
ROCE %
114%
96%
74%
71%
73%
65%
92%
92%
79%
97%
105%
108%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Colgate Palmolive insights

70 extracted metrics across FY03–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 51.00%
  • Public 17.25%
  • DIIs 15.46%
  • FIIs 13.71%
  • Others 2.58%

No promoter shares pledged as of Sep 2026

Change since Jun 2026

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Colgate Palmolive

What does Colgate-Palmolive (India) Ltd do?
Colgate-Palmolive India Ltd is engaged in manufacturing/ trading of toothpaste, tooth powder, toothbrush, mouthwash and personal care products.
Where is Colgate-Palmolive (India) Ltd (COLPAL) listed?
Colgate-Palmolive (India) Ltd trades as COLPAL on the NSE and under code 500830 on the BSE.
Which sector does Colgate-Palmolive (India) Ltd belong to?
Colgate-Palmolive (India) Ltd is classified under the Fast Moving Consumer Goods sector, in the Personal Products industry.
What is the market capitalisation of Colgate-Palmolive (India) Ltd?
Colgate-Palmolive (India) Ltd has a market capitalisation of ₹47,869 Cr as of 20 Nov 2026, which places it in the Midcap band.
What is the PE ratio of Colgate-Palmolive (India) Ltd?
Colgate-Palmolive (India) Ltd trades at a PE ratio of 35.15 as of 20 Nov 2026, on earnings per share of ₹50.07, against a book value of ₹59.45 per share.
What is the 52-week high and low of Colgate-Palmolive (India) Ltd?
Over the last 52 weeks Colgate-Palmolive (India) Ltd has traded between ₹1,563.9 and ₹2,301.6 as of 20 Nov 2026.
Does Colgate-Palmolive (India) Ltd pay dividends?
Colgate-Palmolive (India) Ltd has a dividend yield of 1.35%.
What is the Return on Equity (ROE) of Colgate-Palmolive (India) Ltd?
Colgate-Palmolive (India) Ltd reported a return on equity of 82.70%. Its debt-to-equity ratio is 0.03.

Company Information

Colgate-Palmolive India Ltd is engaged in manufacturing/ trading of toothpaste, tooth powder, toothbrush, mouthwash and personal care products.

CEO Ms. Prabha Narasimhan
Employees 2,198
Listed 17 Dec 2007
Face Value ₹1
Shares Outstanding 27,19,85,634

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/COLPAL.md for Colgate-Palmolive (India) Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More